Results
1 -
4 of
4
(Click
here to explore results)
- Discoveries, target identifications, and biological applications of natural products that inhibit splicing factor 3B subunit 1. Dianne Pham, Kazunori Koide
, Nat. Prod. Rep.
, 2016
, 33
, 637
- Design, synthesis and preliminary biological evaluation of rivastigmine-INDY hybrids as multitarget ligands against Alzheimer's disease by targeting butyrylcholinesterase and DYRK1A/CLK1 kinases. Mihaela-Liliana Ţînţaş, Ludovic Peauger, Anaïs Barré, Cyril Papamicaël, Thierry Besson, Jana Sopkovà-de Oliveira Santos, Vincent Gembus, Vincent Levacher
, RSC Med. Chem.
, 2024
, 15
, 963
- Design and synthesis of conformationally constraint Dyrk1A inhibitors by creating an intramolecular H-bond involving a benzothiazole core. Mohamed Salah, Mohammad Abdel-Halim, Matthias Engel
, Med. Chem. Commun.
, 2018
, 9
, 1045
- Discovery of new Cdc2-like kinase 4 (CLK4) inhibitors via pharmacophore exploration combined with flexible docking-based ligand/receptor contact fingerprints and machine learning. Mai Fayiz Al-Tawil, Safa Daoud, Ma'mon M. Hatmal, Mutasem Omar Taha
, RSC Adv.
, 2022
, 12
, 10686